Capricor Therapeutics, Inc. News: Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
Upcoming Events
There are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases.